#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mucopolysaccharidosis I Heavy menstrual bleeding Tuberous sclerosis complex Toxic epidermal necrolysis Craniocerebral injury Demyelination Cystic fibrosis respiratory infection suppression Congenital megacolon Ductal adenocarcinoma of pancreas Infertility female Rett syndrome Cluster headache Acute graft versus host disease in skin Extra-osseous Ewing's sarcoma metastatic Restless legs syndrome More trials…

    Learn about Rare Diseases

    Vascular malformation – Diagnostics Glomerulonephritis membranous Congenital nephrogenic diabetes insipidus – Basic Information Inclusion body myositis – Basic Information Mucopolysaccharidosis – Basic Information Rett syndrome Methylmalonic acidaemia – Basic Information Familial amyotrophic lateral sclerosis – Diagnostics Pemphigoid – Trials in Disease Niemann-Pick disease – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Protein S Gen1053 Lovotibeglogene Autotemcel Calcium Carbonate Ly3484356 Doxazosin Mesilate Glasdegib ANTI-GD2-800CW Glucagon Itacitinib ANOC-001 Barzolvolimab Oxycodone Hydrochloride Emapalumab Lbl-007 Cefepime Hydrochloride Pimavanserin Tartrate Regtivex Relugolix Follitropin Alfa More therapies…

    Learn about Your Condition

    Meningorrhagia Laparoscopic surgery Gastric cancer recurrent Pancreatic fistula Breast cancer stage II Atrial septal defect Pulmonary resection Diabetic ketoacidosis Univentricular heart Papilloma viral infection Hyperparathyroidism primary Polymyalgia rheumatica Dent's disease Skin cancer Overweight More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Continued Treatment Study for Patients with Blood Cancers Using Tafasitamab

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Haematological malignancy
    Investigated Drugs:
    • Tafasitamab
    Hungary Italy Spain

  • Long-Term Study on the Safety and Effects of RP-L102 Infusion for Patients with Fanconi Anemia Subtype A

    Recruiting

    1 1 1
    Investigated Diseases:
    • Congenital aplastic anaemia
    Investigated Drugs:
    • Autologous Cd34+Enriched Cells From Patients With Fanconi Anemia Subtype A Transduced Ex Vivo With Lentiviral Vector Carrying The Fanconi Anemia Complementation Group A Gene
    Spain

  • Study on Rituximab for Patients with Acute Myocardial Infarction

    Recruiting

    2 1 1
    Investigated Diseases:
    • Electrocardiogram ST segment elevation
    Investigated Drugs:
    • Rituximab
    • Sodium Chloride
    Czechia France Germany The Netherlands Spain

  • Study on the Effect and Safety of Flecainide and Metoprolol for Patients with Arrhythmic Mitral Valve Prolapse

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Mitral valve prolapse
    Investigated Drugs:
    • Metoprolol
    • Flecainide
    Norway

  • Study on Percutaneous Needle Fasciotomy with Methylprednisolone Acetate or Saline for Dupuytren’s Contracture in the Finger Joint

    Recruiting

    3 1 1
    Investigated Diseases:
    • Dupuytren’s contracture
    Investigated Drugs:
    • Anhydrous Lidocaine Hydrochloride
    • Methylprednisolone Acetate
    Denmark

  • Study on Ribociclib and Drug Combination for Patients with Advanced HER2-Negative, Hormone Receptor Positive Breast Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    • Breast cancer female
    • Hormone receptor positive breast cancer
    Investigated Drugs:
    • Anastrozole
    • Exemestane
    • Fulvestrant
    Germany
Previous Page
1 … 571 572 573 574 575 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!